Osaic Holdings
ALXO icon

Osaic Holdings’s ALX Oncology ALXO Stock Holding History

Osaic Holdings’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$62 – 7742
2025
Q1 		$62 Buy
+100
New +$120 ﹤0.01% 7270
2024
Q3 		– Sell
-51
Closed -$308 – 7395
2024
Q2 		$308 Buy
51
+5
+11% +$61 ﹤0.01% 7094
2024
Q1 		$513 Sell
46
-36
-44% -$506 ﹤0.01% 6809
2023
Q4 		$1.22K Sell
82
-100
-55% -$949 ﹤0.01% 6687
2023
Q3 		$873 Buy
+182
New +$988 ﹤0.01% 6863
2022
Q3 		– Sell
-130
Closed -$1K – 7229
2022
Q2 		$1K Hold
130
– – ﹤0.01% 7020
2022
Q1 		$2K Hold
130
– – ﹤0.01% 6841
2021
Q4 		$3K Buy
+130
New +$5.61K ﹤0.01% 6842

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Osaic Holdings's ALXO Position: Q2 2025 in Review

Osaic Holdings sold out of ALX Oncology (ALXO) in Q2 2025, closing a stake of 100 shares — an estimated $62 sold.

Osaic Holdings first reported a position in ALXO in Q4 2021 and held it in 8 quarters. The position peaked at $3K in Q4 2021. 61 funds tracked by Wall St. Rank hold ALXO as of Q2 2025.

  • Osaic Holdings reported no remaining ALX Oncology position as of Q2 2025 after selling out during the quarter.
  • Osaic Holdings sold 100 ALX Oncology shares in Q2 2025, an estimated $62.
  • Osaic Holdings first reported a position in ALX Oncology in Q4 2021 and held it in 8 quarters.
  • Osaic Holdings's ALX Oncology position peaked at $3K in Q4 2021.
  • 61 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2025.

Based on Osaic Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.